Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on November 23, 2005
J Am Soc Nephrol 17: 271-278, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005050566

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005050566v1
17/1/271    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rumpsfeld, M.
Right arrow Articles by Johnson, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rumpsfeld, M.
Right arrow Articles by Johnson, D. W.

Epidemiology and Outcomes

Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zealand Peritoneal Dialysis Patient Populations

Markus Rumpsfeld*,{dagger}, Stephen P. McDonald* and David W. Johnson*,{ddagger}

* Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia; {dagger} Department of Renal Medicine, University of North Norway, Tromso, Norway; and {ddagger} Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

Address correspondence to: Prof. David Johnson, Department of Renal Medicine, Level 2, Ambulatory Renal and Transplant Services Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane Qld 4102, Australia. Phone: +61-7-3240-5080; Fax: +61-7-3240-5480; E-mail: david_johnson{at}health.qld.gov.au

Received for publication May 30, 2005. Accepted for publication October 5, 2005.

Although early studies observed that peritoneal membrane transport characteristics were determinants of morbidity and mortality in peritoneal dialysis (PD) patients, more recent investigations, such as the Ademex trial, have refuted these findings. The aim of this study was to determine whether baseline peritoneal transport status predicted subsequent survival in Australian and New Zealand PD patients. The study included all adult patients in Australia and New Zealand who commenced PD between April 1, 1999, and March 31, 2004, and had a peritoneal equilibration test (PET) performed within 6 mo of PD commencement. Times to death and death-censored technique failure were examined by Kaplan-Meier analyses and multivariate Cox proportional hazards models. PET measurements were available in 3702 (72%) of the 5170 individuals who began PD treatment in Australia or New Zealand during the study period. In these patients, high transporter status was found to be a significant, independent predictor of death-censored technique failure (adjusted hazard ratio [AHR] 1.23; 95% confidence interval [CI] 1.02 to 1.49; P = 0.03) and mortality (AHR 1.34; 95% CI 1.05 to 1.79, P = 0.02) compared with low-average transport status. High-average transport class was also associated with mortality (AHR 1.21; 95% CI 1.00 to 1.48; P = 0.047) but not death-censored technique failure (AHR 1.04; 95% CI 0.90 to 1.21) compared with low-average transport status. When transport status was alternatively analyzed as a continuous variable, dialysate:plasma creatinine ratio at 4 h was independently predictive of both death-censored technique failure (AHR 1.07; 95% CI 1.01 to 1.295; P = 0.031) and death (AHR 1.09; 95% CI 1.01 to 1.373; P = 0.036 per 0.1 change in dialysate:plasma creatinine). Peritoneal transport rate is a highly significant risk factor for both mortality and death-censored technique failure in the Australian and New Zealand incident PD patient populations.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C.-C. Szeto, K.-M. Chow, B. C.-H. Kwan, K.-B. Lai, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li
The relationship between bone morphogenic protein-7 and peritoneal transport characteristics
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2989 - 2994.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Tangri, D. Ansell, and D. Naimark
Predicting technique survival in peritoneal dialysis patients: comparing artificial neural networks and logistic regression
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2972 - 2981.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. J. Wiggins, S. P. McDonald, F. G. Brown, J. B. Rosman, and D. W. Johnson
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3005 - 3012.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Goffin and O. Devuyst
Phenotype and genotype: perspectives for peritoneal dialysis patients
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3018 - 3022.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. S. Brimble, M. Walker, P. J. Margetts, K. K. Kundhal, and C. G. Rabbat
Meta-Analysis: Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2591 - 2598.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP